Drug Therapies and the Risk of Malignancy in Crohn's Disease: Results From the TREAT™ Registry-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Drug Therapies and the Risk of Malignancy in Crohn's Disease: Results From the TREAT™ Registry

Published:2014-02 Issue:2 Volume:109 Page:212-223
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:

Author:

Lichtenstein Gary R,Feagan Brian G,Cohen Russell D,Salzberg Bruce A,Diamond Robert H,Langholff Wayne,Londhe Anil,Sandborn William J

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Link

http://www.nature.com/articles/ajg2013441.pdf

Reference28 articles.

1. , the CESAME Study Group. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.;Beaugerie;Lancet,2009

2. Azathioprine and anti-TNFa therapies in Crohns disease: a review of pharmacology, clinical efficacy and safety.;Arnott;Pharmacol Res,2003

3. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine.;Kandiel;Gut,2005

4. Noncolorectal malignancies in inflammatory bowel disease: more than meets the eye.;Beaugerie;Dig Dis,2009

5. Concomitant use of immunomodulators with anti-TNF in Crohns disease: yes or no?;Meier;Curr Drug Targets,2010

Cited by 157 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety Summary of Pediatric Inflammatory Bowel Disease Therapies;Gastroenterology Clinics of North America;2023-09

2. Risk of uterine cervical cancer in inflammatory bowel disease: a systematic review and meta-analysis;Scandinavian Journal of Gastroenterology;2023-07-30

3. Extraintestinal Cancers in Inflammatory Bowel Disease: A Literature Review;Cancers;2023-07-27

4. Inflammatory Bowel Disease Treatment in Cancer Patients—A Comprehensive Review;Cancers;2023-06-09

5. Personalize, participate, predict, and prevent: 4Ps in inflammatory bowel disease;Frontiers in Medicine;2023-04-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3